Fabian Kiessling

Fabian Kiessling is a Professor and Head of the Institute of Experimental Molecular Imaging at RWTH Aachen University. He leads research in diagnostic probe development and imaging tools for disease-specific therapy monitoring. His work bridges molecular imaging, nanomedicine, and clinical translation. Kiessling holds a medical degree from Heidelberg University and completed residency and habilitation in Radiology at the German Cancer Research Center (DKFZ).

• Affiliations: Helmholtz Institute for Biomedical Engineering, RWTH Aachen University
• Professional Roles: Editor for Radiology, Molecular Imaging and Biology, and others
• Societies: Founding member of ESMOFIR, ESMI board member, former chair of ESR Molecular Imaging subcommittee

Research focuses on nanomedicine, theranostics, and ultrasound-based therapies. Over 400 publications, including book chapters and edited volumes, highlight his contributions to molecular imaging and nanotechnology. Awards include the Emil Salzer Prize and World Molecular Imaging Society Fellowship.

His labs develop imaging-guided therapies and investigate nanoparticle delivery mechanisms. Collaborations span academia and industry, such as founding invivoContrast GmbH for clinical translation of contrast agents.